메뉴 건너뛰기




Volumn , Issue , 2006, Pages 201-216

First Trimester Screening for Aneuploidy

Author keywords

[No Author keywords available]

Indexed keywords


EID: 33747890154     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0300-7.50026-0     Document Type: Chapter
Times cited : (1)

References (66)
  • 1
    • 0033740930 scopus 로고    scopus 로고
    • Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997
    • Egan JF, Benn P, Borgida AF, et al. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 2000, 96:979-985.
    • (2000) Obstet Gynecol , vol.96 , pp. 979-985
    • Egan, J.F.1    Benn, P.2    Borgida, A.F.3
  • 2
    • 0002682681 scopus 로고
    • Prevalence, risk and recurrence
    • Churchill Livingstone, Edinburgh, D.H. Brock, C.H. Rodeck, M.A. Ferguson-Smith (Eds.)
    • Hook EB Prevalence, risk and recurrence. Prenatal Diagnosis and Screening 1992, 351-392. Churchill Livingstone, Edinburgh. D.H. Brock, C.H. Rodeck, M.A. Ferguson-Smith (Eds.).
    • (1992) Prenatal Diagnosis and Screening , pp. 351-392
    • Hook, E.B.1
  • 3
    • 0028849426 scopus 로고
    • Maternal age and gestational age specific risks for chromosomal defects
    • Snijders RJM, Sebire NJ, Nicolaides KH Maternal age and gestational age specific risks for chromosomal defects. Fetal Diag Ther 1995, 10:356-357.
    • (1995) Fetal Diag Ther , vol.10 , pp. 356-357
    • Snijders, R.J.M.1    Sebire, N.J.2    Nicolaides, K.H.3
  • 5
    • 0000922691 scopus 로고
    • Observations on an ethnic classification of idiots
    • Down J.L. Observations on an ethnic classification of idiots. Lond Hosp Rep 1866, 3:259-262.
    • (1866) Lond Hosp Rep , vol.3 , pp. 259-262
    • Down, J.L.1
  • 6
    • 0001105689 scopus 로고
    • Mongoloid imbecility
    • Shuttleworth GE Mongoloid imbecility. Br Med J 1909, 2:661-665.
    • (1909) Br Med J , vol.2 , pp. 661-665
    • Shuttleworth, G.E.1
  • 7
    • 70449245071 scopus 로고
    • Etudes des chromosomes somatiques de neuf enfants mongoliens
    • Lejeune J, Gautier M, Turpin R. Etudes des chromosomes somatiques de neuf enfants mongoliens. C R Acad Sci 1959, 248:1721.
    • (1959) C R Acad Sci , vol.248 , pp. 1721
    • Lejeune, J.1    Gautier, M.2    Turpin, R.3
  • 10
    • 50549169392 scopus 로고
    • Multiple congenital anomaly caused by an extra auto-some
    • Patau K, Smith DW, Therman E, et al. Multiple congenital anomaly caused by an extra auto-some. Lancet 1960, 1:790-793.
    • (1960) Lancet , vol.1 , pp. 790-793
    • Patau, K.1    Smith, D.W.2    Therman, E.3
  • 11
    • 0007807354 scopus 로고    scopus 로고
    • Recommendations arising from the 32nd Study Group: screening for down syndrome in the first trimester
    • Royal College of Obstetricians and Gynaecologists, RCOG Press, London, J.G. Grudzinskas, R.H.T. Ward (Eds.)
    • Royal College of Obstetricians and Gynaecologists Recommendations arising from the 32nd Study Group: screening for down syndrome in the first trimester. Screening for Down Syndrome in the First Trimester 1997, 353-356. RCOG Press, London. J.G. Grudzinskas, R.H.T. Ward (Eds.).
    • (1997) Screening for Down Syndrome in the First Trimester , pp. 353-356
  • 12
    • 0032999749 scopus 로고    scopus 로고
    • A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A
    • Spencer K, Souter V, Tul N, et al. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999, 13:231-237.
    • (1999) Ultrasound Obstet Gynecol , vol.13 , pp. 231-237
    • Spencer, K.1    Souter, V.2    Tul, N.3
  • 13
    • 0036179264 scopus 로고    scopus 로고
    • Point of care screening for chromosomal anomalies in the first trimester
    • Spencer K. Point of care screening for chromosomal anomalies in the first trimester. Clin Chem 2002, 48:403-404.
    • (2002) Clin Chem , vol.48 , pp. 403-404
    • Spencer, K.1
  • 14
    • 0037333249 scopus 로고    scopus 로고
    • Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years prospective experience
    • Spencer K, Spencer CE, Power M, et al. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years prospective experience. Br J Obstet Gynaecol 2003, 110:281-286.
    • (2003) Br J Obstet Gynaecol , vol.110 , pp. 281-286
    • Spencer, K.1    Spencer, C.E.2    Power, M.3
  • 15
    • 33947192131 scopus 로고    scopus 로고
    • Screening at the point of care: Down syndrome-a case study
    • AACC Press, Washington, C.P. Price, A. St John, J.M. Hicks (Eds.)
    • Spencer K. Screening at the point of care: Down syndrome-a case study. Point of Care Testing. 2004, 333-339. AACC Press, Washington. C.P. Price, A. St John, J.M. Hicks (Eds.).
    • (2004) Point of Care Testing. , pp. 333-339
    • Spencer, K.1
  • 16
    • 0032710295 scopus 로고    scopus 로고
    • Screening for trisomy 18 by fetal nuchal translucency, maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation
    • Tul N, Spencer K, Noble P, et al. Screening for trisomy 18 by fetal nuchal translucency, maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 1999, 19:1035-1042.
    • (1999) Prenat Diagn , vol.19 , pp. 1035-1042
    • Tul, N.1    Spencer, K.2    Noble, P.3
  • 17
    • 0034073499 scopus 로고    scopus 로고
    • Screening for trisomy 13 by fetal nuchal translucency thickness and maternal serum free β-hCG and PAPP-A at 10-14 weeks
    • Spencer K, Ong C, Skentou H, et al. Screening for trisomy 13 by fetal nuchal translucency thickness and maternal serum free β-hCG and PAPP-A at 10-14 weeks. Prenat Diagn 2000, 20:411-416.
    • (2000) Prenat Diagn , vol.20 , pp. 411-416
    • Spencer, K.1    Ong, C.2    Skentou, H.3
  • 18
    • 0036796080 scopus 로고    scopus 로고
    • A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β-hCG and PAPP-A
    • Spencer K, Nicolaides KH A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β-hCG and PAPP-A. Prenat Diagn 2002, 22:877-879.
    • (2002) Prenat Diagn , vol.22 , pp. 877-879
    • Spencer, K.1    Nicolaides, K.H.2
  • 19
    • 0034108953 scopus 로고    scopus 로고
    • Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy
    • Spencer K, Berry E, Crossley JA, et al. Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy. Prenat Diagn 2000, 20:311-317.
    • (2000) Prenat Diagn , vol.20 , pp. 311-317
    • Spencer, K.1    Berry, E.2    Crossley, J.A.3
  • 20
    • 0025011297 scopus 로고
    • The mathematical basis of multivariate risk analysis: with special reference to screening for Down syndrome associated pregnancy
    • Reynolds T, Penney M. The mathematical basis of multivariate risk analysis: with special reference to screening for Down syndrome associated pregnancy. Ann Clin Biochem 1990, 27:452-458.
    • (1990) Ann Clin Biochem , vol.27 , pp. 452-458
    • Reynolds, T.1    Penney, M.2
  • 21
    • 0001179668 scopus 로고    scopus 로고
    • UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation
    • Snijders RJM, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1999, 18:519-521.
    • (1999) Lancet , vol.18 , pp. 519-521
    • Snijders, R.J.M.1    Noble, P.2    Sebire, N.3
  • 22
    • 0029588613 scopus 로고
    • Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
    • Pandya PP, Snijders RJM, Johnson SP, et al. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 1995, 102:957-962.
    • (1995) Br J Obstet Gynaecol , vol.102 , pp. 957-962
    • Pandya, P.P.1    Snijders, R.J.M.2    Johnson, S.P.3
  • 23
  • 24
    • 84882497237 scopus 로고    scopus 로고
    • National Institute for Clinical Excellence Antenatal care: routine care for the healthy pregnant woman. Clinical Guidance No. 6, 2003. healthy pregnant woman. Clinical Guidance No. 6.
    • (2003)
  • 25
  • 26
    • 16244402632 scopus 로고    scopus 로고
    • Committee Opinion No. 296. First trimester screening for fetal aneuploidy
    • ACOG
    • ACOG Committee Opinion No. 296. First trimester screening for fetal aneuploidy. Obstet Gynecol 2004, 104:215-217.
    • (2004) Obstet Gynecol , vol.104 , pp. 215-217
  • 27
    • 0141613852 scopus 로고    scopus 로고
    • Rapid and simple antenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods of FISH and QF-PCR
    • Hulten MA, Dhanjal S, Pertl B. Rapid and simple antenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods of FISH and QF-PCR. Reproduction 2003, 126:279-297.
    • (2003) Reproduction , vol.126 , pp. 279-297
    • Hulten, M.A.1    Dhanjal, S.2    Pertl, B.3
  • 28
    • 0036378243 scopus 로고    scopus 로고
    • One stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies
    • Bindra R, Heath V, Liao A, et al. One stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies. Ultrasound Obstet Gynecol 2002, 20:219-225.
    • (2002) Ultrasound Obstet Gynecol , vol.20 , pp. 219-225
    • Bindra, R.1    Heath, V.2    Liao, A.3
  • 29
    • 0027447232 scopus 로고
    • Age-specific detection and false positive rates: an aid to counseling in Down's Syndrome risk screening
    • Reynolds TM, Nix AB, Dunstan FD, et al. Age-specific detection and false positive rates: an aid to counseling in Down's Syndrome risk screening. Obstet Gynecol 1993, 81:447-450.
    • (1993) Obstet Gynecol , vol.81 , pp. 447-450
    • Reynolds, T.M.1    Nix, A.B.2    Dunstan, F.D.3
  • 30
    • 0034792982 scopus 로고    scopus 로고
    • Age related detection and false positive rates when screening for Down's Syndrome in the first trimester using fetal nuchal translucency and maternal serum free a-hCG and PAPP-A
    • Spencer K. Age related detection and false positive rates when screening for Down's Syndrome in the first trimester using fetal nuchal translucency and maternal serum free a-hCG and PAPP-A. Br J Obstet Gynaecol 2001, 108:1043-1046.
    • (2001) Br J Obstet Gynaecol , vol.108 , pp. 1043-1046
    • Spencer, K.1
  • 31
    • 0034062921 scopus 로고    scopus 로고
    • Maternal serum free β-hCG and PAPP-A in fetal sex chromosome defects in the first trimester
    • Spencer K, Tul N, Nicolaides KH Maternal serum free β-hCG and PAPP-A in fetal sex chromosome defects in the first trimester. Prenat Diagn 2000, 20:390-394.
    • (2000) Prenat Diagn , vol.20 , pp. 390-394
    • Spencer, K.1    Tul, N.2    Nicolaides, K.H.3
  • 32
    • 0034041082 scopus 로고    scopus 로고
    • Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation
    • Spencer K, Liao AWJ, Skentou H, et al. Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000, 20:852-853.
    • (2000) Prenat Diagn , vol.20 , pp. 852-853
    • Spencer, K.1    Liao, A.W.J.2    Skentou, H.3
  • 33
    • 0037333795 scopus 로고    scopus 로고
    • Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years experience
    • Spencer K, Nicolaides KH Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years experience. Br J Obstet Gynaecol 2003, 110:276-280.
    • (2003) Br J Obstet Gynaecol , vol.110 , pp. 276-280
    • Spencer, K.1    Nicolaides, K.H.2
  • 35
    • 0035685960 scopus 로고    scopus 로고
    • Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype
    • Ghi T, Huggon IC, Zosmer N, et al. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001, 18:610-614.
    • (2001) Ultrasound Obstet Gynecol , vol.18 , pp. 610-614
    • Ghi, T.1    Huggon, I.C.2    Zosmer, N.3
  • 36
    • 0035080229 scopus 로고    scopus 로고
    • Limitations of using first trimester nuchal translucency measurement in routine screening for major congenital heart defects
    • Mavrides E, Cobian-Sanchez F, Tekay A, et al. Limitations of using first trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001, 17:106-110.
    • (2001) Ultrasound Obstet Gynecol , vol.17 , pp. 106-110
    • Mavrides, E.1    Cobian-Sanchez, F.2    Tekay, A.3
  • 37
    • 0034920539 scopus 로고    scopus 로고
    • Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester
    • Souka AP, Krampl E, Bakalis S, et al. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001, 18:9-17.
    • (2001) Ultrasound Obstet Gynecol , vol.18 , pp. 9-17
    • Souka, A.P.1    Krampl, E.2    Bakalis, S.3
  • 38
    • 0033799683 scopus 로고    scopus 로고
    • First trimester maternal serum a-human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications
    • Ong CYT, Liao AW, Spencer K, et al. First trimester maternal serum a-human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. Br J Obstet Gynaecol 2000, 107:1265-1270.
    • (2000) Br J Obstet Gynaecol , vol.107 , pp. 1265-1270
    • Ong, C.Y.T.1    Liao, A.W.2    Spencer, K.3
  • 39
    • 0036281056 scopus 로고    scopus 로고
    • Early pregnancy levels of pregnancy associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth
    • Smith GCS, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002, 87:1762-1767.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 1762-1767
    • Smith, G.C.S.1    Stenhouse, E.J.2    Crossley, J.A.3
  • 40
    • 0037182856 scopus 로고    scopus 로고
    • Early pregnancy origins of low birth weight
    • Smith GCS, Stenhouse EJ, Crossley JA, et al. Early pregnancy origins of low birth weight. Nature 2002, 417:916.
    • (2002) Nature , vol.417 , pp. 916
    • Smith, G.C.S.1    Stenhouse, E.J.2    Crossley, J.A.3
  • 41
    • 0036733227 scopus 로고    scopus 로고
    • Decreased first trimester PAPP-A is a predictor of adverse outcome
    • Yaron Y, Heifetz S, Ochshorn Y, et al. Decreased first trimester PAPP-A is a predictor of adverse outcome. Prenat Diagn 2002, 22:778-782.
    • (2002) Prenat Diagn , vol.22 , pp. 778-782
    • Yaron, Y.1    Heifetz, S.2    Ochshorn, Y.3
  • 42
    • 0347478051 scopus 로고    scopus 로고
    • Predicting complications of pregnancy with first trimester maternal serum free β-hCG, PAPP-A and inhibin-A
    • Tul N, Pusenjak S, Osredkar J, et al. Predicting complications of pregnancy with first trimester maternal serum free β-hCG, PAPP-A and inhibin-A. Prenat Diagn 2003, 23:990-996.
    • (2003) Prenat Diagn , vol.23 , pp. 990-996
    • Tul, N.1    Pusenjak, S.2    Osredkar, J.3
  • 43
    • 0033899471 scopus 로고    scopus 로고
    • Second trimester antenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complication with adverse outcome
    • Spencer K. Second trimester antenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complication with adverse outcome. Prenat Diagn 2000, 20:652-656.
    • (2000) Prenat Diagn , vol.20 , pp. 652-656
    • Spencer, K.1
  • 45
    • 0030048402 scopus 로고    scopus 로고
    • Justifying prenatal screening and genetic amniocentesis programs by cost-effectiveness analyses: a re-evaluation
    • Ganiats TG Justifying prenatal screening and genetic amniocentesis programs by cost-effectiveness analyses: a re-evaluation. Med Decis Making 1996, 16:45-50.
    • (1996) Med Decis Making , vol.16 , pp. 45-50
    • Ganiats, T.G.1
  • 46
    • 0033858982 scopus 로고    scopus 로고
    • Recent economic evaluations of antenatal screening: a systematic review and critique
    • Petrou S, Henderson J, Roberts T, et al. Recent economic evaluations of antenatal screening: a systematic review and critique. J Med Screen 2000, 7:59-73.
    • (2000) J Med Screen , vol.7 , pp. 59-73
    • Petrou, S.1    Henderson, J.2    Roberts, T.3
  • 47
    • 0034052693 scopus 로고    scopus 로고
    • Cost-benefit analysis of prenatal diagnosis for Down syndrome using the British or the American approach
    • Vintzileos AM, Ananth CV, Smulian JC, et al. Cost-benefit analysis of prenatal diagnosis for Down syndrome using the British or the American approach. Obstet Gynecol 2000, 95:577-583.
    • (2000) Obstet Gynecol , vol.95 , pp. 577-583
    • Vintzileos, A.M.1    Ananth, C.V.2    Smulian, J.C.3
  • 48
    • 0035949076 scopus 로고    scopus 로고
    • Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies
    • Gilbert RE, Augood C, Gupta R, et al. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ 2001, 323:423-425.
    • (2001) BMJ , vol.323 , pp. 423-425
    • Gilbert, R.E.1    Augood, C.2    Gupta, R.3
  • 49
    • 0036856194 scopus 로고    scopus 로고
    • Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis
    • Caughey AB, Kuppermann M, Norton ME, et al. Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis. Am J Obstet Gynecol 2002, 187:1239-1245.
    • (2002) Am J Obstet Gynecol , vol.187 , pp. 1239-1245
    • Caughey, A.B.1    Kuppermann, M.2    Norton, M.E.3
  • 50
    • 0036291453 scopus 로고    scopus 로고
    • An increase in cost effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing
    • Christiansen M, Olesen Larsen S. An increase in cost effectiveness of first trimester maternal screening programmes for fetal chromosome anomalies is obtained by contingent testing. Prenat Diagn 2002, 22:482-486.
    • (2002) Prenat Diagn , vol.22 , pp. 482-486
    • Christiansen, M.1    Olesen Larsen, S.2
  • 52
    • 85045797401 scopus 로고    scopus 로고
    • First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)
    • Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003, 7:11.
    • (2003) Health Technol Assess , vol.7 , pp. 11
    • Wald, N.J.1    Rodeck, C.2    Hackshaw, A.K.3
  • 53
    • 0027320802 scopus 로고
    • An economic appraisal of alternative pre-natal screening programmes fro Down's syndrome
    • Shackley P, McGuire A, Boyd PA, et al. An economic appraisal of alternative pre-natal screening programmes fro Down's syndrome. J Public Health Med 1993, 15:175-184.
    • (1993) J Public Health Med , vol.15 , pp. 175-184
    • Shackley, P.1    McGuire, A.2    Boyd, P.A.3
  • 54
    • 0023186030 scopus 로고
    • An economic appraisal of screening for Down's Syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration
    • Gill M, Murday V, Slack J. An economic appraisal of screening for Down's Syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration. Soc Sci Med 1987, 24:725-731.
    • (1987) Soc Sci Med , vol.24 , pp. 725-731
    • Gill, M.1    Murday, V.2    Slack, J.3
  • 56
    • 0029650542 scopus 로고
    • Economic costs of birth defects and cerebral palsy-United States, 1992
    • Waitzman N, Romano P, Scheffler R, et al. Economic costs of birth defects and cerebral palsy-United States, 1992. MMWR Recomm Rep 1995, 44:694-699.
    • (1995) MMWR Recomm Rep , vol.44 , pp. 694-699
    • Waitzman, N.1    Romano, P.2    Scheffler, R.3
  • 57
    • 0032406152 scopus 로고    scopus 로고
    • Economic evaluation of prenatal screening for Down syndrome in the USA
    • Beazoglou T, Heffley D, Kyriopoulos J, et al. Economic evaluation of prenatal screening for Down syndrome in the USA. Prenat Diagn 1998, 18:1241-1252.
    • (1998) Prenat Diagn , vol.18 , pp. 1241-1252
    • Beazoglou, T.1    Heffley, D.2    Kyriopoulos, J.3
  • 58
    • 0033157130 scopus 로고    scopus 로고
    • Cost and effectiveness of the California triple maker prenatal screening program
    • Cunningham GC, Tompkinson DG Cost and effectiveness of the California triple maker prenatal screening program. Genet Med 1999, 1:199-206.
    • (1999) Genet Med , vol.1 , pp. 199-206
    • Cunningham, G.C.1    Tompkinson, D.G.2
  • 59
    • 1642423677 scopus 로고    scopus 로고
    • An outcome analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years
    • Biggio JR, Morris C, Owen J, et al. An outcome analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Am J Obstet Gynecol 2004, 190:721-729.
    • (2004) Am J Obstet Gynecol , vol.190 , pp. 721-729
    • Biggio, J.R.1    Morris, C.2    Owen, J.3
  • 60
    • 0036417261 scopus 로고    scopus 로고
    • British National Health Service's and women's costs of antenatal ultrasound screening and follow-up tests
    • Henderson J, Bricker L, Roberts T, et al. British National Health Service's and women's costs of antenatal ultrasound screening and follow-up tests. Ultrasound Obstet Gynaecol 2002, 20:154-162.
    • (2002) Ultrasound Obstet Gynaecol , vol.20 , pp. 154-162
    • Henderson, J.1    Bricker, L.2    Roberts, T.3
  • 61
    • 0007807354 scopus 로고    scopus 로고
    • RCOG Recommendations arising from the 32nd Study Group: screening for Down syndrome in the first trimester
    • RCOG Press, London, J.G. Grudzinskas, R.H.T. Ward (Eds.)
    • RCOG Recommendations arising from the 32nd Study Group: screening for Down syndrome in the first trimester. Screening for Down syndrome in the first trimester. 1997, 353-356. RCOG Press, London. J.G. Grudzinskas, R.H.T. Ward (Eds.).
    • (1997) Screening for Down syndrome in the first trimester. , pp. 353-356
  • 62
    • 0028113312 scopus 로고
    • Abortion mortality, United States, 1972-1987
    • Lawson HW, Frye A, Atrash HK, et al. Abortion mortality, United States, 1972-1987. Am J Obstet Gynecol 1994, 171:1365-1372.
    • (1994) Am J Obstet Gynecol , vol.171 , pp. 1365-1372
    • Lawson, H.W.1    Frye, A.2    Atrash, H.K.3
  • 63
    • 0030693283 scopus 로고    scopus 로고
    • Women's opinions and the implications of first-versus second trimester screening for fetal Down's syndrome
    • Kornman LH, Wortelboer MJM, Beekhuis JR, et al. Women's opinions and the implications of first-versus second trimester screening for fetal Down's syndrome. Prenat Diagn 1997, 17:1011-1018.
    • (1997) Prenat Diagn , vol.17 , pp. 1011-1018
    • Kornman, L.H.1    Wortelboer, M.J.M.2    Beekhuis, J.R.3
  • 64
    • 0033795010 scopus 로고    scopus 로고
    • Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome
    • Mulvey S, Wallace EM Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome. Br J Obstet Gynaecol 2000, 107:1302-1305.
    • (2000) Br J Obstet Gynaecol , vol.107 , pp. 1302-1305
    • Mulvey, S.1    Wallace, E.M.2
  • 65
    • 0032517577 scopus 로고    scopus 로고
    • Antenatal screening for Down's syndrome
    • Monni G, Ibba RM, Zoppi MA Antenatal screening for Down's syndrome. Lancet 1998, 352:1631-1632.
    • (1998) Lancet , vol.352 , pp. 1631-1632
    • Monni, G.1    Ibba, R.M.2    Zoppi, M.A.3
  • 66
    • 10644241716 scopus 로고    scopus 로고
    • Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies
    • Spencer K, Aitken D. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies. Ultrasound Obstet Gynecol 2004, 24:735-739.
    • (2004) Ultrasound Obstet Gynecol , vol.24 , pp. 735-739
    • Spencer, K.1    Aitken, D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.